Brief: Agile Therapeutics Says In Q1 2022 Twirla Cycles Dispensed Increased 29% To 16,602
14/04/2022 21:42
April 14 (Reuters) - Agile Therapeutics Inc AGRX.O :
* AGILE THERAPEUTICS INC - AGILE THERAPEUTICS ANNOUNCES
FIRST
QUARTER 2022 PRESCRIPTION DATA FOR TWIRLA
* AGILE THERAPEUTICS INC - DURING FIRST QUARTER 2022 TWIRLA
CYCLES
DISPENSED INCREASED 29% TO 16,602
* AGILE THERAPEUTICS INC - DURING THE FIRST QUARTER 2022
TOTAL
PRESCRIPTIONS (TRX) OF TWIRLA INCREASED 27% TO 12,494
Further company coverage: AGRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Agile Therapeutics
See all newsBrief: Agile Therapeutics Inc. Announces Definitive Merger Agreement With Insud Pharma, S.L.
Agile Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Agile Therapeutics Announces Delisting From Nasdaq
Agile Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview
Brief: Agile Therapeutics Completes Pay-Off Of Debt